ArticleJournal of cellular and molecular medicine2021

Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.

Junnan Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.